Serendipity Partners

What they do

Serendipity Partners was established to secure a dedicated source of capital to invest in the healthcare area, leveraging successful long-term experience in company management and sector expertise. The fund will invest in companies that conduct the majority of their business or otherwise have a principal connection to Europe. The fund will have a special emphasis on the Nordics (Norway, Sweden, Finland, Denmark, and Island). The remainder Northern European countries will also be a focus area. The fund has established a well-connected network of senior healthcare professionals, covering several European countries that will help to source deals in a proprietary manner. The Fund is registered by The Financial Supervisory Authority of Norway and has approximately NOK 800 mill under management. The Healthcare fund will acquire controlling positions, but also non-majority positions in which the business can be influenced in a value creating manner (e.g., board representation or similar positions, shareholder agreements or similar agreements). The main focus of the fund will be mature cash flow positive companies, but the fund may invest up to 20% in earlier stage companies. Half of the investments can be in public companies. The fund will target companies within a number of healthcare sectors, including pharmaceutical/nutraceuticals, diagnostics, novel products for lowering of health care spending, medical devices, and healthcare providers. Deals are evaluated through a well-tested Private Equity framework. We seek to become partners with public and family business owners, management teams, and excellent CEOs who have as their goal significant long-term growth in their enterprise. We believe that we have assembled the culture, philosophy, tools, knowledge and skills necessary to support this growth-journey.

What they look for

Invests in sustainable, cash-flow positive healthcare companies that benefit patients and society, seeking influential ownership positions and driving growth organically or through acquisitions without excessive leverage.

Stage

Series B+

Sectors

Healthcare

Based

Oslo, NO